This public procurement contract involves the supply of medicinal products, specifically contrast agents, as detailed in the specifications and conditions outlined in Appendix 2 (Sample Purchase Agreement) and Appendix 3 (Price Offer) of the procurement documentation published on the buyer's profile
Contract awarded. Originally published 8 months ago.
This public procurement contract involves the supply of medicinal products as specified in the attached documents. The contract is divided into five parts according to the specifications provided in the documentation. Suppliers are invited to submit their offers based on the detailed requirements ou
This public procurement contract involves the supply of a theragnostic application system, including necessary accessories and related consumables as specified in Appendix 2 of the tender documentation (contract templates). Additionally, it includes the provision of related supplies and services as
This public procurement contract is for the supply of a genetic analyzer specifically designed for Sanger sequencing and fragment analysis. It includes the provision of related consumables as specified in the relevant appendices of the tender documentation. Suppliers are invited to submit their prop
This public procurement contract involves the supply of a medicinal product, specifically Fludeoxyglucose-(18F), as detailed in the specifications and conditions outlined in attachments 2 (Public Procurement Specifications) and 3 (Sample Purchase Agreement) of the tender documentation. The contract
Supply non-clinical consumables including forms, labels, and packaging for pathology and primary care services.
Procurement of RSV immunisation vaccine products for adult populations, scheduled for 2028.
Procurement for meningococcal ACWY vaccine supply in 2027 from qualified manufacturers or distributors.
Procurement opportunity for MMR vaccine supply with anticipated delivery timeline of 2027.
